{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:57:51Z","timestamp":1788904671111,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2508106"],"award-info":[{"award-number":["2023YFC2508106"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82430101"],"award-info":[{"award-number":["82430101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovation Program of Shanghai Municipal Education Commission","award":["2025GDZKZD06"],"award-info":[{"award-number":["2025GDZKZD06"]}]},{"name":"Shanghai Dermatology Research Centre","award":["2023ZZ02017"],"award-info":[{"award-number":["2023ZZ02017"]}]},{"name":"Clinical Research Plan of SHDC","award":["SHDC22022302"],"award-info":[{"award-number":["SHDC22022302"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04120-y","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:14:52Z","timestamp":1771064092000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Topical delivery of high-drug-loading nanoparticle gels for psoriasis treatment"],"prefix":"10.1186","volume":"24","author":[{"given":"Zihan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Xia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"key":"4120_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s40824-021-00226-6","volume":"25","author":"WY Jeong","year":"2021","unstructured":"Jeong WY, Kwon M, Choi HE, Kim KS. Recent advances in transdermal drug delivery systems: a review. Biomater Res. 2021;25:24. https:\/\/doi.org\/10.1186\/s40824-021-00226-6.","journal-title":"Biomater Res"},{"key":"4120_CR2","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1021\/acs.molpharmaceut.3c00126","volume":"20","author":"N Schafer","year":"2023","unstructured":"Schafer N, Balwierz R, Biernat P, Och\u0119dzan-Siod\u0142ak W, Lipok J. Natural ingredients of transdermal drug delivery systems as permeation enhancers of active substances through the stratum corneum. Mol Pharm. 2023;20:3278\u201397. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c00126.","journal-title":"Mol Pharm"},{"key":"4120_CR3","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/s13346-021-00909-6","volume":"12","author":"D Ramadon","year":"2022","unstructured":"Ramadon D, McCrudden MTC, Courtenay AJ, Donnelly RF. Enhancement strategies for transdermal drug delivery systems: current trends and applications. Drug Deliv Transl Res. 2022;12:758\u201391. https:\/\/doi.org\/10.1007\/s13346-021-00909-6.","journal-title":"Drug Deliv Transl Res"},{"key":"4120_CR4","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1126\/science.abo0693","volume":"376","author":"TA Harris-Tryon","year":"2022","unstructured":"Harris-Tryon TA, Grice EA. Microbiota and maintenance of skin barrier function. Science. 2022;376:940\u20135. https:\/\/doi.org\/10.1126\/science.abo0693.","journal-title":"Science"},{"key":"4120_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s41702-020-0058-7","volume":"4","author":"B Kim","year":"2020","unstructured":"Kim B, Cho H-E, Moon SH, Ahn H-J, Bae S, Cho H-D, et al. Transdermal delivery systems in cosmetics. Biomed Dermatol. 2020;4:10. https:\/\/doi.org\/10.1186\/s41702-020-0058-7.","journal-title":"Biomed Dermatol"},{"key":"4120_CR6","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1177\/0091270009344984","volume":"49","author":"JJ Escobar-Ch\u00e1vez","year":"2009","unstructured":"Escobar-Ch\u00e1vez JJ, Bonilla-Mart\u00ednez D, Villegas-Gonz\u00e1lez MA, Revilla-V\u00e1zquez AL. Electroporation as an efficient physical enhancer for skin drug delivery. J Clin Pharmacol. 2009;49:1262\u201383. https:\/\/doi.org\/10.1177\/0091270009344984.","journal-title":"J Clin Pharmacol"},{"key":"4120_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.106598","volume":"105","author":"K Singpanna","year":"2025","unstructured":"Singpanna K, Suriyaamporn P, Pornpitchanarong C, Ngawhirunpat T, Li SK, Opanasopit P. Chitosan-gold nanoparticles: a trend of skin permeation enhancement effect in animal and human skin model. J Drug Deliv Sci Technol. 2025;105:106598. https:\/\/doi.org\/10.1016\/j.jddst.2025.106598.","journal-title":"J Drug Deliv Sci Technol"},{"key":"4120_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jconrel.2011.05.003","volume":"154","author":"JW Lee","year":"2011","unstructured":"Lee JW, Gadiraju P, Park JH, Allen MG, Prausnitz MR. Microsecond thermal ablation of skin for transdermal drug delivery. J Control Release. 2011;154:58\u201368. https:\/\/doi.org\/10.1016\/j.jconrel.2011.05.003.","journal-title":"J Control Release"},{"key":"4120_CR9","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.biopha.2018.10.078","volume":"109","author":"T Waghule","year":"2019","unstructured":"Waghule T, Singhvi G, Dubey SK, Pandey MM, Gupta G, Singh M, et al. Microneedles: a smart approach and increasing potential for transdermal drug delivery system. Biomed Pharmacother. 2019;109:1249\u201358. https:\/\/doi.org\/10.1016\/j.biopha.2018.10.078.","journal-title":"Biomed Pharmacother"},{"key":"4120_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjidi.2023.100197","volume":"3","author":"J Chang","year":"2023","unstructured":"Chang J, Yu B, Saltzman WM, Girardi M. Nanoparticles as a therapeutic delivery system for skin cancer prevention and treatment. JID Innovations. 2023;3:100197. https:\/\/doi.org\/10.1016\/j.xjidi.2023.100197.","journal-title":"JID Innovations"},{"key":"4120_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscia.2023.100031","volume":"2","author":"ZH Mok","year":"2024","unstructured":"Mok ZH. The effect of particle size on drug bioavailability in various parts of the body. Pharmaceutical Science Advances. 2024;2:100031. https:\/\/doi.org\/10.1016\/j.pscia.2023.100031.","journal-title":"Pharmaceutical Science Advances"},{"key":"4120_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20:101\u201324. https:\/\/doi.org\/10.1038\/s41573-020-0090-8.","journal-title":"Nat Rev Drug Discov"},{"key":"4120_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06219-6","volume":"23","author":"M Bhat","year":"2025","unstructured":"Bhat M, Tharmatt A, Bhargava S, Kumeria T, Mishra A, Mittal A, et al. Can breakthroughs in dermal and transdermal macromolecule delivery surmount existing barriers and revolutionize future therapeutics? J Transl Med. 2025;23:513. https:\/\/doi.org\/10.1186\/s12967-025-06219-6.","journal-title":"J Transl Med"},{"key":"4120_CR14","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1002\/cplu.202000496","volume":"85","author":"Y Liu","year":"2020","unstructured":"Liu Y, Yang G, Jin S, Xu L, Zhao CX. Development of high-drug\u2010loading nanoparticles. ChemPlusChem. 2020;85:2143\u201357.","journal-title":"ChemPlusChem"},{"key":"4120_CR15","doi-asserted-by":"crossref","unstructured":"Xu L, Wang X, Yang G, Zhao Z, Weng Y, Li Y, Liu Y, Zhao CX. Development of a concentration-controlled sequential nanoprecipitation for making lipid nanoparticles with high drug loading. Aggregate; 2023. e369.","DOI":"10.1002\/agt2.369"},{"key":"4120_CR16","doi-asserted-by":"publisher","first-page":"4750","DOI":"10.1002\/ange.201913539","volume":"132","author":"Y Liu","year":"2020","unstructured":"Liu Y, Yang G, Baby T, Tengjisi, Chen D, Weitz DA, Zhao CX. Stable polymer nanoparticles with exceptionally high drug loading by sequential nanoprecipitation. Angew Chem. 2020;132:4750\u20138.","journal-title":"Angew Chem"},{"key":"4120_CR17","doi-asserted-by":"publisher","unstructured":"Mimansa, Jamwal M, Das R, Shanavas A. (2022). High Drug Loading Nanoparticles Stabilized with Autologous Serum Proteins Passively Inhibits Tumor Growth. Biomacromolecules 23, 5065\u20135073. https:\/\/doi.org\/10.1021\/acs.biomac.2c00907","DOI":"10.1021\/acs.biomac.2c00907"},{"key":"4120_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01655-6","volume":"8","author":"J Guo","year":"2023","unstructured":"Guo J, Zhang H, Lin W, Lu L, Su J, Chen X. Signaling pathways and targeted therapies for psoriasis. Signal Transduct Target Ther. 2023;8:437. https:\/\/doi.org\/10.1038\/s41392-023-01655-6.","journal-title":"Signal Transduct Target Ther"},{"key":"4120_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04523-3","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou X, Chen Y, Cui L, Shi Y, Guo C. Advances in the pathogenesis of psoriasis: from keratinocyte perspective. Cell Death Dis. 2022;13:81. https:\/\/doi.org\/10.1038\/s41419-022-04523-3.","journal-title":"Cell Death Dis"},{"key":"4120_CR20","first-page":"105","volume":"8","author":"L Fala","year":"2015","unstructured":"Fala L. Otezla (Apremilast), an oral PDE-4 inhibitor, receives FDA approval for the treatment of patients with active psoriatic arthritis and plaque psoriasis. Am Health Drug Benefits. 2015;8:105.","journal-title":"Am Health Drug Benefits"},{"key":"4120_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s40780-023-00290-1","volume":"9","author":"R Kadowaki","year":"2023","unstructured":"Kadowaki R, Ogata F, Fushiki A, Daimyo S, Deguchi S, Otake H, et al. Skin absorption of felbinac solid nanoparticles in gel formulation containing l-menthol and carboxypolymethylene. Journal of Pharmaceutical Health Care and Sciences. 2023;9:20. https:\/\/doi.org\/10.1186\/s40780-023-00290-1.","journal-title":"Journal of Pharmaceutical Health Care and Sciences"},{"key":"4120_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2023.113203","volume":"224","author":"H Xiang","year":"2023","unstructured":"Xiang H, Xu S, Zhang W, Li Y, Zhou Y, Miao X. Skin permeation of curcumin nanocrystals: effect of particle size, delivery vehicles, and permeation enhancer. Colloids and Surfaces B: Biointerfaces. 2023;224:113203. https:\/\/doi.org\/10.1016\/j.colsurfb.2023.113203.","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"key":"4120_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cytogfr.2014.10.009","volume":"26","author":"L Grine","year":"2015","unstructured":"Grine L, Dejager L, Libert C, Vandenbroucke RE. An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17. Cytokine Growth Factor Rev. 2015;26:25\u201333. https:\/\/doi.org\/10.1016\/j.cytogfr.2014.10.009.","journal-title":"Cytokine Growth Factor Rev"},{"key":"4120_CR24","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.jaci.2003.08.049","volume":"112","author":"I Nomura","year":"2003","unstructured":"Nomura I, Gao B, Boguniewicz M, Darst MA, Travers JB, Leung DYM. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol. 2003;112:1195\u2013202. https:\/\/doi.org\/10.1016\/j.jaci.2003.08.049.","journal-title":"J Allergy Clin Immunol"},{"key":"4120_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1155\/MI.2005.273","volume":"2005","author":"O Arican","year":"2005","unstructured":"Arican O, Aral M, Sasmaz S, Ciragil P. Serum levels of TNF-\u03b1, IFN\u2010\u03b3, IL\u20106, IL\u20108, IL\u201012, IL\u201017, and IL\u201018 in patients with active psoriasis and correlation with disease severity. Mediat Inflamm. 2005;2005:273\u20139.","journal-title":"Mediat Inflamm"},{"key":"4120_CR26","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jid.2018.07.025","volume":"139","author":"Y Cai","year":"2019","unstructured":"Cai Y, Xue F, Quan C, Qu M, Liu N, Zhang Y, et al. A critical role of the IL-1\u03b2\u2013IL-1R signaling pathway in skin inflammation and psoriasis pathogenesis. J Invest Dermatol. 2019;139:146\u201356.","journal-title":"J Invest Dermatol"},{"key":"4120_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemphyslip.2021.105055","volume":"236","author":"S Knox","year":"2021","unstructured":"Knox S, O\u2019Boyle NM. Skin lipids in health and disease: a review. Chem Phys Lipids. 2021;236:105055. https:\/\/doi.org\/10.1016\/j.chemphyslip.2021.105055.","journal-title":"Chem Phys Lipids"},{"key":"4120_CR28","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1002\/eji.201343801","volume":"43","author":"B Flutter","year":"2013","unstructured":"Flutter B, Nestle FO. TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis. Eur J Immunol. 2013;43:3138\u201346.","journal-title":"Eur J Immunol"},{"key":"4120_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2019.10.004","volume":"316","author":"AD Permana","year":"2019","unstructured":"Permana AD, Tekko IA, McCrudden MT, Anjani QK, Ramadon D, McCarthy HO, et al. Solid lipid nanoparticle-based dissolving microneedles: a promising intradermal lymph targeting drug delivery system with potential for enhanced treatment of lymphatic filariasis. J Control Release. 2019;316:34\u201352.","journal-title":"J Control Release"},{"key":"4120_CR30","doi-asserted-by":"publisher","first-page":"5028","DOI":"10.1021\/acs.molpharmaceut.4c00459","volume":"21","author":"M Railic","year":"2024","unstructured":"Railic M, Crean AM, Vucen S. Unravelling microarray patch performance: the role of in vitro release medium and biorelevant testing. Mol Pharm. 2024;21:5028\u201340.","journal-title":"Mol Pharm"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04120-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04120-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04120-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T16:44:20Z","timestamp":1774284260000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04120-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4120"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04120-y","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in accordance with protocols approved by the Adelaide University Animal Ethics Committee (Approval No. S-2022-088).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"252"}}